Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | COVID-19 | Research

Trending prevalence of healthcare-associated infections in a tertiary hospital in China during the COVID-19 pandemic

Authors: Rong Rong, Lanxi Lin, Yongjie Yang, Shumin Zhao, Ruiling Guo, Junpeng Ye, Xinghua Zhu, Qiong Wen, Dayue Liu

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

The purpose of this study was to demonstrate both the four-year prevalence trend of healthcare-associated infections (HAIs) in a large tertiary hospital and the trend regarding the prevalence of HAIs following the outbreak of coronavirus disease 2019 (COVID-19) in order to provide evidence of hospital infection management during the COVID-19 pandemic.

Methods

Based on the hospital’s electronic nosocomial infection databases related to HAIs, we retrospectively identified the HAI cases to assess the epidemiological characteristics of HAIs from January 1, 2018, to December 31, 2021, in a large tertiary hospital in China. Similarly, the trends of HAIs after the COVID-19 outbreak and the seasonal variation of HAIs were further analyzed.

Results

The HAI cases (n = 7833) were identified from the inpatients (n = 483,258) during the 4 years. The most frequently occurring underlying cause of HAIs was respiratory tract infections (44.47%), followed by bloodstream infections (11.59%), and urinary tract infections (8.69%). The annual prevalence of HAIs decreased from 2.39% in 2018 to 1.41% in 2021 (P = 0.032), with the overall prevalence of HAIs significantly decreasing since the outbreak of COVID-19 (2.20% in 2018–2019 vs. 1.44% in 2020–2021, P < 0.001). The prevalence of respiratory tract infections decreased most significantly; whereas, overall, the prevalence of HAIs was significantly greater during the winter compared with the rest of the year.

Conclusions

Not only did the annual prevalence of HAIs decrease from 2018 to 2021, but it also significantly decreased since the start of the COVID-19 pandemic, particularly respiratory tract infections. These results provide evidence for the need to prevent HAIs, especially during the winter season.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allegranzi B, Bagheri NS, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–41.CrossRef Allegranzi B, Bagheri NS, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–41.CrossRef
2.
go back to reference Wang J, Liu F, Tartari E, Huang J, Harbarth S, Pittet D, et al. The prevalence of healthcare-associated infections in Mainland China: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(6):701–9.CrossRef Wang J, Liu F, Tartari E, Huang J, Harbarth S, Pittet D, et al. The prevalence of healthcare-associated infections in Mainland China: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(6):701–9.CrossRef
3.
go back to reference World Health Organization. Report on the burden of endemic health care-associated infection worldwide. Geneva: World Health Organization; 2011. World Health Organization. Report on the burden of endemic health care-associated infection worldwide. Geneva: World Health Organization; 2011.
4.
go back to reference Liu X, Spencer A, Long Y, Greenhalgh C, Steeg S, Verma A. A systematic review and meta-analysis of disease burden of healthcare-associated infections in China: an economic burden perspective from general hospitals. J Hosp Infect. 2022;123:1–11.CrossRef Liu X, Spencer A, Long Y, Greenhalgh C, Steeg S, Verma A. A systematic review and meta-analysis of disease burden of healthcare-associated infections in China: an economic burden perspective from general hospitals. J Hosp Infect. 2022;123:1–11.CrossRef
5.
go back to reference Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–208.CrossRef Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–208.CrossRef
6.
go back to reference Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516.CrossRef Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516.CrossRef
7.
go back to reference Ling ML, Apisarnthanarak A, Madriaga G. The burden of healthcare-associated infections in Southeast Asia: a systematic literature review and meta-analysis. Clin Infect Dis. 2015;60(11):1690–9.CrossRef Ling ML, Apisarnthanarak A, Madriaga G. The burden of healthcare-associated infections in Southeast Asia: a systematic literature review and meta-analysis. Clin Infect Dis. 2015;60(11):1690–9.CrossRef
8.
go back to reference Zhang Y, Zhong ZF, Chen SX, Zhou DR, Li ZK, Meng Y, et al. Prevalence of healthcare-associated infections and antimicrobial use in China: results from the 2018 point prevalence survey in 189 hospitals in Guangdong Province. Int J Infect Dis. 2019;89:179–84.CrossRef Zhang Y, Zhong ZF, Chen SX, Zhou DR, Li ZK, Meng Y, et al. Prevalence of healthcare-associated infections and antimicrobial use in China: results from the 2018 point prevalence survey in 189 hospitals in Guangdong Province. Int J Infect Dis. 2019;89:179–84.CrossRef
9.
go back to reference Zhang Y, Zhang J, Wei D, Yang Z, Wang Y, Yao Z. Annual surveys for point-prevalence of healthcare-associated infection in a tertiary hospital in Beijing, China, 2012–2014. BMC Infect Dis. 2016;16:161.CrossRef Zhang Y, Zhang J, Wei D, Yang Z, Wang Y, Yao Z. Annual surveys for point-prevalence of healthcare-associated infection in a tertiary hospital in Beijing, China, 2012–2014. BMC Infect Dis. 2016;16:161.CrossRef
10.
go back to reference You CQ, Zhu ZH, Cheng YS, Huang B, Wang P. Investigation and analysis of quality control indicators for healthcare-associated infections in 118 hospitals of Guizhou province. Chin J Nosocomial Infect. 2016;26(17):4. You CQ, Zhu ZH, Cheng YS, Huang B, Wang P. Investigation and analysis of quality control indicators for healthcare-associated infections in 118 hospitals of Guizhou province. Chin J Nosocomial Infect. 2016;26(17):4.
11.
go back to reference Xie DS, Xiong W, Xiang LL, Fu XY, Yu YH, Liu L, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007–2008. J Hosp Infect. 2010;76(2):150–5.CrossRef Xie DS, Xiong W, Xiang LL, Fu XY, Yu YH, Liu L, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007–2008. J Hosp Infect. 2010;76(2):150–5.CrossRef
12.
go back to reference Chen Y, Zhao JY, Shan X, Han XL, Tian SG, Chen FY, et al. A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals. J Hosp Infect. 2017;95(1):105–11.CrossRef Chen Y, Zhao JY, Shan X, Han XL, Tian SG, Chen FY, et al. A point-prevalence survey of healthcare-associated infection in fifty-two Chinese hospitals. J Hosp Infect. 2017;95(1):105–11.CrossRef
13.
go back to reference Ereth MH, Fine J, Stamatatos F, Mathew B, Hess D, Simpser E. Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures. J Hosp Infect. 2021;116:69–77.CrossRef Ereth MH, Fine J, Stamatatos F, Mathew B, Hess D, Simpser E. Healthcare-associated infection impact with bioaerosol treatment and COVID-19 mitigation measures. J Hosp Infect. 2021;116:69–77.CrossRef
14.
go back to reference National Health Commission. Diagnostic criteria for nosocomial infection (in Chinese). Chin Med J. 2001;81:314–20. National Health Commission. Diagnostic criteria for nosocomial infection (in Chinese). Chin Med J. 2001;81:314–20.
15.
go back to reference Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.CrossRef Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.CrossRef
16.
go back to reference Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat-Simul Comput. 2009;38:1228–34.CrossRef Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat-Simul Comput. 2009;38:1228–34.CrossRef
17.
go back to reference Abulhasan YB, Rachel SP, Châtillon-Angle MO, Alabdulraheem N, Schiller I, Dendukuri N, et al. Healthcare-associated infections in the neurological intensive care unit: results of a 6-year surveillance study at a major tertiary care center. Am J Infect Control. 2018;46(6):656–62.CrossRef Abulhasan YB, Rachel SP, Châtillon-Angle MO, Alabdulraheem N, Schiller I, Dendukuri N, et al. Healthcare-associated infections in the neurological intensive care unit: results of a 6-year surveillance study at a major tertiary care center. Am J Infect Control. 2018;46(6):656–62.CrossRef
18.
go back to reference Mazzeffi M, Galvagno S, Rock C. Prevention of healthcare-associated infections in intensive care unit patients. Anesthesiology. 2021;135(6):1122–31.CrossRef Mazzeffi M, Galvagno S, Rock C. Prevention of healthcare-associated infections in intensive care unit patients. Anesthesiology. 2021;135(6):1122–31.CrossRef
19.
go back to reference Magill SS, O’Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in US hospitals. N Engl J Med. 2018;379(18):1732–44.CrossRef Magill SS, O’Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in US hospitals. N Engl J Med. 2018;379(18):1732–44.CrossRef
20.
go back to reference Plachouras D, Kärki T, Hansen S, Hopkins S, Lyytikäinen O, Moro ML, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill. 2018;23(46):1800393.CrossRef Plachouras D, Kärki T, Hansen S, Hopkins S, Lyytikäinen O, Moro ML, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill. 2018;23(46):1800393.CrossRef
21.
go back to reference Kranz J, Schmidt S, Wagenlehner F, Schneidewind L. Catheter-associated urinary tract infections in adult patients. Deutsches Arzteblatt Int. 2020;117(6):83–8. Kranz J, Schmidt S, Wagenlehner F, Schneidewind L. Catheter-associated urinary tract infections in adult patients. Deutsches Arzteblatt Int. 2020;117(6):83–8.
22.
go back to reference Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022;43(1):12–25.CrossRef Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022;43(1):12–25.CrossRef
23.
go back to reference Leung N, Chu D, Shiu E, Chan KH, McDevitt JJ, Hau B, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–80.CrossRef Leung N, Chu D, Shiu E, Chan KH, McDevitt JJ, Hau B, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–80.CrossRef
24.
go back to reference Jia R, Lu L, Li S, Liu P, Xu M, Cao L, et al. Human rhinoviruses prevailed among children in the setting of wearing face masks in Shanghai, 2020. BMC Infect Dis. 2022;22(1):253.CrossRef Jia R, Lu L, Li S, Liu P, Xu M, Cao L, et al. Human rhinoviruses prevailed among children in the setting of wearing face masks in Shanghai, 2020. BMC Infect Dis. 2022;22(1):253.CrossRef
25.
go back to reference Mäkinen TM, Juvonen R, Jokelainen J, Harju TH, Peitso A, Bloigu A, et al. Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med. 2009;103(3):456–62.CrossRef Mäkinen TM, Juvonen R, Jokelainen J, Harju TH, Peitso A, Bloigu A, et al. Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med. 2009;103(3):456–62.CrossRef
26.
go back to reference Jaakkola K, Saukkoriipi A, Jokelainen J, Juvonen R, Kauppila J, Vainio O, et al. Decline in temperature and humidity increases the occurrence of influenza in cold climate. Environ Health. 2014;13(1):22.CrossRef Jaakkola K, Saukkoriipi A, Jokelainen J, Juvonen R, Kauppila J, Vainio O, et al. Decline in temperature and humidity increases the occurrence of influenza in cold climate. Environ Health. 2014;13(1):22.CrossRef
27.
go back to reference Richet H. Seasonality in Gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012;18(10):934–40.CrossRef Richet H. Seasonality in Gram-negative and healthcare-associated infections. Clin Microbiol Infect. 2012;18(10):934–40.CrossRef
28.
go back to reference Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998–2011. Open Forum Infect Dis. 2017;4(1): w281.CrossRef Simmering JE, Tang F, Cavanaugh JE, Polgreen LA, Polgreen PM. The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998–2011. Open Forum Infect Dis. 2017;4(1): w281.CrossRef
29.
go back to reference Simmering JE, Polgreen LA, Cavanaugh JE, Erickson BA, Suneja M, Polgreen PM. Warmer weather and the risk of urinary tract infections in women. J Urol. 2021;205(2):500–6.CrossRef Simmering JE, Polgreen LA, Cavanaugh JE, Erickson BA, Suneja M, Polgreen PM. Warmer weather and the risk of urinary tract infections in women. J Urol. 2021;205(2):500–6.CrossRef
Metadata
Title
Trending prevalence of healthcare-associated infections in a tertiary hospital in China during the COVID-19 pandemic
Authors
Rong Rong
Lanxi Lin
Yongjie Yang
Shumin Zhao
Ruiling Guo
Junpeng Ye
Xinghua Zhu
Qiong Wen
Dayue Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07952-9

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.